Welcome to LookChem.com Sign In|Join Free
  • or
7-Hydroxycoumarin, also known as umbelliferone, is a naturally occurring compound found in many plants and is a metabolite of coumarin. It has a variety of applications in different industries due to its unique properties.

93-35-6

Post Buying Request

93-35-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

93-35-6 Usage

Uses

Used in Pharmaceutical Industry:
7-Hydroxycoumarin is used as an antifungal agent and a phytoalexin, which helps protect plants from fungal infections.
Used in Cosmetics Industry:
7-Hydroxycoumarin is used as a sunscreen agent in sunscreen lotions and creams, providing protection against harmful UV rays.
Used in Research and Diagnostics:
7-Hydroxycoumarin is used as an intracellular pH-sensitive fluorescent indicator and a blood-brain barrier probe, aiding in research and diagnostic applications.
Used in Textile Industry:
7-Hydroxycoumarin is used as an optical brightener for textiles, enhancing the appearance of fabrics.
Used in Laser Technology:
7-Hydroxycoumarin has been used as a gain medium for dye lasers, contributing to the development of laser technology.

Purification Methods

It crystallises from water (m 232-232.2o) or EtOH (m 232o). It sublimes at 160o/0.001mm. Fluorescence: Em max 452nm/Exc 325nm in 50% EtOH. [Beilstein 18 H 27, 18 I 306, 18 II 16, 18 III/IV 294, 18/1 V 386.]

Check Digit Verification of cas no

The CAS Registry Mumber 93-35-6 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 93-35:
(4*9)+(3*3)+(2*3)+(1*5)=56
56 % 10 = 6
So 93-35-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H

93-35-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0236)  Umbelliferone  >98.0%(GC)

  • 93-35-6

  • 5g

  • 200.00CNY

  • Detail
  • TCI America

  • (H0236)  Umbelliferone  >98.0%(GC)

  • 93-35-6

  • 25g

  • 595.00CNY

  • Detail
  • Alfa Aesar

  • (L04082)  7-Hydroxycoumarin, 98%   

  • 93-35-6

  • 25g

  • 401.0CNY

  • Detail
  • Alfa Aesar

  • (L04082)  7-Hydroxycoumarin, 98%   

  • 93-35-6

  • 100g

  • 1341.0CNY

  • Detail
  • Vetec

  • (V900776)  Umbelliferone  Vetec reagent grade, 98%

  • 93-35-6

  • V900776-25G

  • 179.01CNY

  • Detail
  • Vetec

  • (V900776)  Umbelliferone  Vetec reagent grade, 98%

  • 93-35-6

  • V900776-100G

  • 573.30CNY

  • Detail
  • Aldrich

  • (H24003)  Umbelliferone  99%

  • 93-35-6

  • H24003-10G

  • 226.98CNY

  • Detail
  • Aldrich

  • (H24003)  Umbelliferone  99%

  • 93-35-6

  • H24003-25G

  • 360.36CNY

  • Detail
  • Aldrich

  • (H24003)  Umbelliferone  99%

  • 93-35-6

  • H24003-100G

  • 2,204.28CNY

  • Detail
  • Sigma

  • (93979)  Umbelliferone  suitable for fluorescence indicator, ≥98.0% (HPLC)

  • 93-35-6

  • 93979-25G

  • 753.48CNY

  • Detail
  • Sigma

  • (93979)  Umbelliferone  suitable for fluorescence indicator, ≥98.0% (HPLC)

  • 93-35-6

  • 93979-100G

  • 2,511.99CNY

  • Detail
  • Sigma-Aldrich

  • (54826)  Umbelliferone  analytical standard

  • 93-35-6

  • 54826-50MG

  • 329.94CNY

  • Detail

93-35-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name umbelliferone

1.2 Other means of identification

Product number -
Other names UMBELLIFERON

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:93-35-6 SDS

93-35-6Synthetic route

5-hydroxy-2-vinylphenyl acrylate
1516900-23-4

5-hydroxy-2-vinylphenyl acrylate

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidine][benzylidene]ruthenium(II) dichloride In dichloromethane at 37℃; for 24h; Reagent/catalyst; Solvent;99%
7-(benzyloxy)-2H-chromen-2-one
31005-04-6

7-(benzyloxy)-2H-chromen-2-one

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; ethanethiol In dichloromethane at 30℃; for 72h;98.8%
With boron trifluoride diethyl etherate; ethanethiol In dichloromethane at 30℃; for 72h; Product distribution; Other reagent: Me2S instead of EtSH. Investigation of the debenzylation of the 4-methyl derivative.;98.8%
With iodine In 2,2'-[1,2-ethanediylbis(oxy)]bisethanol at 120℃; for 2h;70%
7-prenyloxycoumarin
10387-50-5

7-prenyloxycoumarin

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dichloromethane at 20℃; for 1h;98%
at 200℃;
7-methoxycoumarin
531-59-9

7-methoxycoumarin

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With Pyridine hydrobromide In sulfolane at 150 - 160℃; for 7h; Inert atmosphere;98%
With aluminum (III) chloride In toluene for 3h; Reflux;86%
With 1-n-butyl-3-methylimidazolim bromide; toluene-4-sulfonic acid; 1-butyl-3-methylimidazolium Tetrafluoroborate at 115℃; for 13h;80%
7-allyloxycoumarin
31005-03-5

7-allyloxycoumarin

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With ammonium formate; palladium on activated charcoal In methanol for 1h; Heating;98%
With boron trichloride; tetra-(n-butyl)ammonium iodide In dichloromethane at -78 - 20℃; for 2h; dealkylation;96%
Multi-step reaction with 4 steps
1.1: ozone; DMF / CH2Cl2 / -30 °C
1.2: 62 percent / dimethylsulfide
2.1: rabbit muscle aldolase; (2-hydroxypropyl)-β-cyclodextrin / 48 h / 20 °C / pH 7.5
2.2: 35 percent / acid phoshatase / pH 4.8
3.1: transketolase extract
4.1: bovine serum albumin; Tris buffer / pH 8.2
View Scheme
7-acetyloxycoumarin
10387-49-2

7-acetyloxycoumarin

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With methanol; zinc97%
With sodium hydrogen telluride; acetic acid In ethanol for 0.5h; Heating;90%
With mesoporous silica-supported (Salen) Co(II) catalyst In methanol at 20℃; for 1.5h; chemoselective reaction;90%
With entrapped lipase-PEG In hexane; isopropyl alcohol at 36℃; Enzyme kinetics; Further Variations:; Reagents;
malic acid
617-48-1

malic acid

recorcinol
108-46-3

recorcinol

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With sulfuric acid for 0.0583333h; Microwave irradiation;92%
With sulfuric acid at 100℃; for 2.5h;74.2%
With sulfuric acid at 20 - 100℃; for 3h; von Pechmann Cycloaddition;71%
Propiolic acid
471-25-0

Propiolic acid

recorcinol
108-46-3

recorcinol

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With ytterbium(III) trifluoromethanesulfonate hydrate at 80℃; for 0.0333333h; Reagent/catalyst; Microwave irradiation;92%
With para-chlorotoluene; zeolite H-beta at 150℃; for 20h;60%
With H-BEA In various solvent(s) at 150℃; for 20h;60%
With iron(III) chloride; silver trifluoromethanesulfonate; trifluoroacetic acid In 1,2-dichloro-ethane at 30℃; for 15h;59%
With iron(III) chloride; silver trifluoromethanesulfonate In 1,2-dichloro-ethane; trifluoroacetic acid at 30℃;55%
Resorcinol monoacetate
102-29-4

Resorcinol monoacetate

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With formic acid; rhodium(II) acetate dimer; sodium acetate In neat (no solvent) at 100℃; for 3h; Molecular sieve; Inert atmosphere; regioselective reaction;92%
7-furoyloxycoumarin
94739-97-6

7-furoyloxycoumarin

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

8-(Furan-2-carbonyl)-7-hydroxy-chromen-2-one
94740-05-3

8-(Furan-2-carbonyl)-7-hydroxy-chromen-2-one

C

6-(Furan-2-carbonyl)-7-hydroxy-chromen-2-one
94740-04-2

6-(Furan-2-carbonyl)-7-hydroxy-chromen-2-one

Conditions
ConditionsYield
In ethanol for 48h; Irradiation;A 90%
B 80 mg
C 170 %
In ethanol for 48h; Irradiation;A 90 mg
B 80 mg
C 170 mg
In ethanol for 48h; Irradiation;A 90 mg
B 80 mg
C 170 mg
7-ethoxymethoxychromen-2-one

7-ethoxymethoxychromen-2-one

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With boron trichloride; tetra-(n-butyl)ammonium iodide In dichloromethane at -78℃; for 1h; dealkylation;90%
7-(methoxymethoxy)-2H-chromen-2-one
80754-21-8

7-(methoxymethoxy)-2H-chromen-2-one

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid In neat (no solvent, solid phase) at 20℃; for 0.583333h; Green chemistry;90%
chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With molecular sieve; sodium methylate; triphenylphosphine Wittig reaction; microwave irradiation;88%
With sodium methylate; magnesium oxide; triphenylphosphine Wittig reaction;85%
methyl chloroacetate
96-34-4

methyl chloroacetate

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With sodium methylate; triphenylphosphine at 80 - 210℃; for 5.5h; Ionic liquid;88%
propynoic acid ethyl ester
623-47-2

propynoic acid ethyl ester

recorcinol
108-46-3

recorcinol

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With zinc(II) chloride at 100℃; for 0.5h; neat (no solvent); regioselective reaction;85%
With indium(III) chloride at 90℃; for 2h; Michael addition;52%
Stage #1: propynoic acid ethyl ester; recorcinol With zinc(II) chloride In 1,4-dioxane for 24h; Reflux;
Stage #2: With hydrogenchloride In 1,4-dioxane; water
40%
In 1,4-dioxane for 24h; Reflux;
methyl chloroacetate
96-34-4

methyl chloroacetate

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

3-(2’,4’-dihydroxyphenyl)-(E)-propenoic acid methyl ester

3-(2’,4’-dihydroxyphenyl)-(E)-propenoic acid methyl ester

Conditions
ConditionsYield
With 1-(2-OPPh2-propyl)-3-methylimidazolium hexafluorophosphate; sodium methylate at 110℃; for 0.183333h; Horner-Wadsworth-Emmons olefination; Ionic liquid; Microwave irradiation;A 84%
B 16%
Propiolic acid
471-25-0

Propiolic acid

recorcinol
108-46-3

recorcinol

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

5-hydroxycoumarin
6093-67-0

5-hydroxycoumarin

Conditions
ConditionsYield
With trifluoroacetic acid In chlorobenzene at 100℃; for 6h; Inert atmosphere;A 81%
B 5%
With trifluorormethanesulfonic acid In chlorobenzene at 100℃; for 6h;A 81%
B 5%
Dowex 50x2-200 at 120℃; for 0.166667h; microwave irradiation (30 W);A 69%
B 31%
Dowex 50x2-200 at 120℃; for 0.166667h; Product distribution; microwave irradiation (30 W); other temperature and reaction time; also without microwave irradiation ; also under reflux in p-ClC6H4CH3 in the presence of Amberlyst;
ethyl acetoacetate
141-97-9

ethyl acetoacetate

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With piperidine In ethanol at 20℃; for 0.5h; Knoevenagel Condensation;75%
methyl (triphenylphosphoranylidene)acetate
21204-67-1

methyl (triphenylphosphoranylidene)acetate

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
Stage #1: methyl (triphenylphosphoranylidene)acetate; 2,4-Dihydroxybenzaldehyde In methanol at 20℃; Wittig Olefination;
Stage #2: In methanol at 40 - 50℃; for 9h; UV-irradiation;
74%
ethyl (triphenylphosphoranylidene)acetate
1099-45-2

ethyl (triphenylphosphoranylidene)acetate

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With N,N-diethylaniline for 0.25h; Heating;70%
ethyl (triphenylphosphoranylidene)acetate
1099-45-2

ethyl (triphenylphosphoranylidene)acetate

2,4-Dihydroxybenzaldehyde
95-01-2

2,4-Dihydroxybenzaldehyde

A

(E)-3-(2,4-dihydroxyphenyl)acrylic acid ethyl ester
149542-04-1

(E)-3-(2,4-dihydroxyphenyl)acrylic acid ethyl ester

B

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
In toluene at 60℃; Wittig reaction;A 70%
B n/a
4-Bromoresorcinol
6626-15-9

4-Bromoresorcinol

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With palladium diacetate; potassium hydrogencarbonate at 140℃; for 0.233333h; Heck reaction; Microwave irradiation; neat (no solvent);70%
7-allyloxycoumarin
31005-03-5

7-allyloxycoumarin

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

7-(2-oxopropoxy)-2H-1-benzopyran-2-one
36914-75-7

7-(2-oxopropoxy)-2H-1-benzopyran-2-one

Conditions
ConditionsYield
With oxygen; copper dichloride; palladium dichloride In water; N,N-dimethyl-formamide at 25℃; for 6h;A n/a
B 65%
2-(2,4-Dihydroxy-benzyl)-3,3-dimethyl-pent-4-enoic acid methyl ester
135656-81-4

2-(2,4-Dihydroxy-benzyl)-3,3-dimethyl-pent-4-enoic acid methyl ester

A

3-(1,1-dimethylallyl)-7-hydroxycoumarin
56881-08-4

3-(1,1-dimethylallyl)-7-hydroxycoumarin

B

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With palladium on activated charcoal In diphenylether Heating;A 25%
B 50%
7-(vinyloxy)-2H-chromen-2-one

7-(vinyloxy)-2H-chromen-2-one

3,6-di(2'-pyridyl)-1,2,4,5-tetrazine
1671-87-0

3,6-di(2'-pyridyl)-1,2,4,5-tetrazine

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

3,6-di(pyridin-2'-yl)-s-tetrazine
36901-11-8

3,6-di(pyridin-2'-yl)-s-tetrazine

Conditions
ConditionsYield
In dichloromethane at 20℃; for 72h; Inert atmosphere;A 47%
B 50%
(2’’E)-cyclooct-2’’-en-1’’-yl N-(4-{[(2’-oxochromen-7’-yl)oxy]methyl}phenyl)carbamate

(2’’E)-cyclooct-2’’-en-1’’-yl N-(4-{[(2’-oxochromen-7’-yl)oxy]methyl}phenyl)carbamate

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With 4-(1,2,4,5-tetrazin-3-yl)benzoic acid In water; dimethyl sulfoxide at 37℃; Kinetics; Reagent/catalyst; Irradiation;39%
Propiolic acid
471-25-0

Propiolic acid

recorcinol
108-46-3

recorcinol

A

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

B

4,4'-(ethane-1,1-diyl)bis(benzene-1,3-diol)
432041-90-2

4,4'-(ethane-1,1-diyl)bis(benzene-1,3-diol)

Conditions
ConditionsYield
In water for 21h; Reflux;A 1%
B 27%
3-chloroacrylic acid
1609-93-4

3-chloroacrylic acid

recorcinol
108-46-3

recorcinol

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With H-BEA In toluene for 4h; Heating;12%
(E)-3-chloroacrylic acid
2345-61-1

(E)-3-chloroacrylic acid

recorcinol
108-46-3

recorcinol

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With H-BEA In toluene for 4h; Heating;12%
coumarin
91-64-5

coumarin

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With dihydrogen peroxide; zirconium(IV) oxide In water5.7%
With human liver microsome at 37℃; for 0.25h; Kinetics; Oxidation; Enzymatic reaction;
With NADPH-generating system; recombinant human cytochrome P450 or CYP enzymes; dinoprostone In phosphate buffer pH=7.4; Enzyme kinetics; Further Variations:; Reagents; hydroxylation; Enzymatic reaction;
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

allyl bromide
106-95-6

allyl bromide

7-allyloxycoumarin
31005-03-5

7-allyloxycoumarin

Conditions
ConditionsYield
With potassium carbonate In acetone for 5h; Heating;100%
Stage #1: 7-hydroxy-2H-chromen-2-one With potassium carbonate In acetone at 20℃; for 0.0833333h;
Stage #2: allyl bromide In acetone for 3h; Reflux;
100%
With potassium carbonate In acetone at 70℃; for 12h;98.6%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

acetic anhydride
108-24-7

acetic anhydride

7-acetyloxycoumarin
10387-49-2

7-acetyloxycoumarin

Conditions
ConditionsYield
In pyridine; dichloromethane for 0.25h;100%
With SiO2-supported Co(II) Salen complex catalyst at 50℃; for 0.75h;99%
With pyridine In ethyl acetate at 20℃; for 1.5h; Inert atmosphere;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

7-(3-bromopropoxy)−2H-chromen-2-one
69150-28-3

7-(3-bromopropoxy)−2H-chromen-2-one

Conditions
ConditionsYield
With potassium carbonate In acetone for 12h; Reflux;100%
With potassium carbonate In acetonitrile Reflux;86.9%
With potassium carbonate In acetone Reflux;79%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

7-hydroxychroman-2-one
5631-67-4

7-hydroxychroman-2-one

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In acetic acid100%
With palladium 10% on activated carbon; hydrogen In acetic acid at 20℃; for 12h; Inert atmosphere;99%
With palladium 10% on activated carbon; hydrogen; acetic acid at 50℃; under 2550.26 Torr; for 17h;96.5%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

ethyl bromoacetate
105-36-2

ethyl bromoacetate

ethyl 2-((2-oxo-2H-chromen-7-yl)oxy)acetate
72000-18-1

ethyl 2-((2-oxo-2H-chromen-7-yl)oxy)acetate

Conditions
ConditionsYield
With potassium carbonate In acetone for 4h; Heating;100%
With potassium carbonate In acetone for 5h; Heating;98%
Stage #1: 7-hydroxy-2H-chromen-2-one With potassium carbonate In acetone for 0.5h;
Stage #2: ethyl bromoacetate In ethyl acetate at 20℃; for 6h;
96%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

2,6-dichloropyrazine
4774-14-5

2,6-dichloropyrazine

2-chloro-6-(7-coumarinyloxy)-pyrazine
894416-91-2

2-chloro-6-(7-coumarinyloxy)-pyrazine

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 90℃; for 5h; Inert atmosphere;100%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

iodomethane-d3
865-50-9

iodomethane-d3

[methyl-2H3]7-methoxycoumarin

[methyl-2H3]7-methoxycoumarin

Conditions
ConditionsYield
With potassium carbonate In acetone100%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

3-bromo-7-hydroxy-2H-1-benzopyran-2-one
146900-52-9

3-bromo-7-hydroxy-2H-1-benzopyran-2-one

Conditions
ConditionsYield
With N-chloro-succinimide; copper(II) chloride monohydrate; zinc(II) chloride In acetonitrile at 20℃; for 0.0833333h; regioselective reaction;99.5%
With N-Bromosuccinimide at 20℃; for 2h; regioselective reaction;92%
With γ-picolinium bromochromate In acetonitrile at 90℃; for 1.66667h; regioselective reaction;83%
2-(2-bromoethoxy)tetrahydropyran
17739-45-6, 59146-56-4

2-(2-bromoethoxy)tetrahydropyran

7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

7-[2-(tetrahydro-2H-2-pyranyloxy)ethoxy]-2H-2-chromenone
201813-16-3

7-[2-(tetrahydro-2H-2-pyranyloxy)ethoxy]-2H-2-chromenone

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃; Etherification;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Methyl 4-bromobutyrate
4897-84-1

Methyl 4-bromobutyrate

C14H14O5

C14H14O5

Conditions
ConditionsYield
With 18-crown-6 ether; potassium carbonate In N,N-dimethyl-formamide at 50℃; for 24h;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

1-halopropane

1-halopropane

7-propoxy-2H-chromen-2-one
6093-73-8

7-propoxy-2H-chromen-2-one

Conditions
ConditionsYield
With potassium carbonate In acetone at 80℃; for 1h;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

haloethane

haloethane

7-ethoxycoumarin
31005-02-4

7-ethoxycoumarin

Conditions
ConditionsYield
With potassium carbonate In acetone at 80℃; for 1h;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

halomethane

halomethane

7-methoxycoumarin
531-59-9

7-methoxycoumarin

Conditions
ConditionsYield
With potassium carbonate In acetone at 80℃; for 1h;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

3-bromophenyltrimethylammonium iodide

3-bromophenyltrimethylammonium iodide

7-methoxycoumarin
531-59-9

7-methoxycoumarin

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 80℃; for 3h; Solvent;99%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

benzyl bromide
100-39-0

benzyl bromide

7-(benzyloxy)-2H-chromen-2-one
31005-04-6

7-(benzyloxy)-2H-chromen-2-one

Conditions
ConditionsYield
With potassium carbonate In acetone for 72h; Heating;98%
With potassium carbonate In acetone for 4h; Inert atmosphere; Reflux;95%
Stage #1: 7-hydroxy-2H-chromen-2-one With potassium carbonate In acetone for 0.25h; Inert atmosphere; Reflux;
Stage #2: benzyl bromide In acetone Inert atmosphere; Reflux;
91%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

umbelliprenine
23838-17-7

umbelliprenine

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran; dimethyl sulfoxide for 2h; Heating;98%
With potassium carbonate In acetone at 20℃; for 12h;83%
With potassium carbonate In acetone for 6h; Reflux;80%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

3-chloro-2-butanone
4091-39-8

3-chloro-2-butanone

7-((3-oxobutan-2-yl)oxy)-2H-chromen-2-one
156006-08-5

7-((3-oxobutan-2-yl)oxy)-2H-chromen-2-one

Conditions
ConditionsYield
With potassium carbonate; sodium iodide In acetone at 0 - 60℃;98%
With potassium carbonate In acetone for 24h; Heating;62%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

7-(methoxymethoxy)-2H-chromen-2-one
80754-21-8

7-(methoxymethoxy)-2H-chromen-2-one

Conditions
ConditionsYield
With sodium hydroxide; methyltrialkyl(C8-C10)ammonium chloride (Adogen 464) In dichloromethane for 2h;98%
Stage #1: 7-hydroxy-2H-chromen-2-one With sodium hydride In tetrahydrofuran; N,N-dimethyl-formamide at 0℃; for 3h; Inert atmosphere;
Stage #2: chloromethyl methyl ether In tetrahydrofuran; N,N-dimethyl-formamide at 0 - 20℃; for 17h; Inert atmosphere;
89.2%
With sodium hydride 1.) THF, DMF, RT, 3 h, 2.) THF, DMF, RT, 17 h; Yield given. Multistep reaction;
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

1-dodecylbromide
143-15-7

1-dodecylbromide

7-(dodecyloxy)coumarin
85389-85-1

7-(dodecyloxy)coumarin

Conditions
ConditionsYield
With potassium hydroxide In acetone for 24h; Reflux; Inert atmosphere;98%
With potassium hydroxide In acetone for 24h; Inert atmosphere; Reflux;98%
With potassium carbonate In N,N-dimethyl-formamide for 30h; Heating;60%
With potassium hydroxide In acetone at 68℃; for 24h; Inert atmosphere;
With potassium hydroxide In acetone at 68℃; for 24h; Inert atmosphere;
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

propargyl bromide
106-96-7

propargyl bromide

7-(propynyloxy)-2H-chromen-2-one
67268-42-2

7-(propynyloxy)-2H-chromen-2-one

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 80℃; for 2h;98%
With potassium carbonate In acetone for 8h; Reflux;97%
With potassium carbonate In acetone at 50℃; for 18h;95%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

Ethyl 2-bromopropionate
535-11-5, 41978-69-2

Ethyl 2-bromopropionate

ethyl 2-[(2-oxo-2H-chromen-7-yl)oxy]propanoate
314262-30-1

ethyl 2-[(2-oxo-2H-chromen-7-yl)oxy]propanoate

Conditions
ConditionsYield
With potassium carbonate In acetone for 5h; Heating;98%
Stage #1: 7-hydroxy-2H-chromen-2-one With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.333333h;
Stage #2: Ethyl 2-bromopropionate In N,N-dimethyl-formamide at 90℃; for 5h;
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

7-Hydroxycoumarin benzenesulfonate

7-Hydroxycoumarin benzenesulfonate

Conditions
ConditionsYield
With pyridine for 0.5h; Heating;98%
With pyridine for 0.5h;98%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

tert-butyl (1S,5S)-5-methyl-4-oxocyclohex-2-enyl carbonate
954390-26-2

tert-butyl (1S,5S)-5-methyl-4-oxocyclohex-2-enyl carbonate

7-((1S,5S)-5-methyl-4-oxocyclohex-2-enyloxy)-2H-chromen-2-one
1232680-29-3

7-((1S,5S)-5-methyl-4-oxocyclohex-2-enyloxy)-2H-chromen-2-one

Conditions
ConditionsYield
With tris(dibenzylideneacetone)dipalladium(0) chloroform complex; triphenylphosphine In dichloromethane at 0℃; Inert atmosphere;98%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

dimethyl acetylenedicarboxylate
762-42-5

dimethyl acetylenedicarboxylate

7-methoxycoumarin
531-59-9

7-methoxycoumarin

Conditions
ConditionsYield
With 1-methyl-1H-imidazole In neat (no solvent) at 100℃; for 0.0666667h; Microwave irradiation; Green chemistry;98%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

8-halo-2,6-dimethylocta-2,6-diene

8-halo-2,6-dimethylocta-2,6-diene

7-(3,7-dimethylocta-2,6-dienyloxy)-2H-1-benzopyran-2-one
29527-66-0

7-(3,7-dimethylocta-2,6-dienyloxy)-2H-1-benzopyran-2-one

Conditions
ConditionsYield
With potassium carbonate In acetone at 80℃; for 1h;98%

93-35-6Related news

XAFS study of bioactive Cu(II) complexes of 7-Hydroxycoumarin (cas 93-35-6) derivatives in organic solvents07/24/2019

We characterize the structure of two Cu(II) complexes of 7-hydroxycoumarins in organic solvents. The solvents are, dimethyl sulfoxide and dimethylformamide. X-ray absorption spectroscopy together with density functional theory calculations are employed to identify the structural changes induced ...detailed

Activation of β1-adrenoceptor triggers oxidative stress mediated myocardial membrane destabilization in isoproterenol induced myocardial infarcted rats: 7-Hydroxycoumarin (cas 93-35-6) and its counter action07/23/2019

Activation of β1-adrenoceptor stimulates myocardial membrane destabilization in isoproterenol induced rats. Male albino Wistar rats were pre and co-treated with 7-hydroxycoumarin (16 mg/kg body weight) daily for 8 days. Myocardial infarction was induced into rats by the subcutaneous administrat...detailed

Incorporation of photoluminescent 7-Hydroxycoumarin (cas 93-35-6) units onto a polyethylene matrix by means of gamma radiation07/20/2019

A 60Co source generating gamma radiations was used to graft polyethylene (PE) films with acryloyl chloride (AC). Different doses of radiations (2, 4, 6 and 8 kGy) were employed in order to obtain polymers with different amount of grafted ramifications. Furthermore, the desired photoluminescent p...detailed

7-Hydroxycoumarin (cas 93-35-6) modulates the oxidative metabolism, degranulation and microbial killing of human neutrophils07/21/2019

In the present study, we assessed whether 7-hydroxycoumarin (umbelliferone), 7-hydroxy-4-methylcoumarin, and their acetylated analogs modulate some of the effector functions of human neutrophils and display antioxidant activity. These compounds decreased the ability of neutrophils to generate su...detailed

Hepatoprotective effect of 7-Hydroxycoumarin (cas 93-35-6) against Methyl glyoxal toxicity via activation of Nrf207/19/2019

Methyl glyoxal (MG), a major precursor of advanced glycation end-products, has been identified as significant in the progression of several diseases including aging, diabetes and neurodegenerative diseases as well as causing hepatic damages. 7-hydroxycoumarin (7-HC), a natural-occurring derivati...detailed

Combination of 7-Hydroxycoumarin (cas 93-35-6) in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action07/18/2019

A novel compound, Cou-platin, composed of 7-hydroxycoumarin and a platinum(IV) moiety derived from cisplatin was designed and synthesized. Significantly, Cou-platin exhibited more potent in vitro antitumor activity against all tested cancer cell lines than that of cisplatin, which was mainly att...detailed

Structural investigation of Cu(II) complexes with dibromo 7-Hydroxycoumarin (cas 93-35-6) derivatives using methodology based on XAS07/17/2019

Two new copper(II) complexes based on 6/8-acetyl-3,8/6-dibromo-7-hydroxy-4-methylcoumarin have been synthesized and structurally characterized. The electrochemical synthesis has been applied to enforce the complexation reaction. Characterization of non-crystalline product have been performed usi...detailed

Synthesis and evaluation of bi-functional 7-Hydroxycoumarin (cas 93-35-6) platinum(IV) complexes as antitumor agents07/16/2019

A series of bi-functional 7-hydroxycoumarin platinum(IV) complexes were synthesized, characterized, and evaluated for antitumor activities. The 7-hydroxycoumarin platinum(IV) complexes display moderate to effective antitumor activities toward the tested cell lines and show much potential in over...detailed

Inhibition of human cytochrome P450 2A6 by 7-Hydroxycoumarin (cas 93-35-6) analogues: Analysis of the structure-activity relationship and isoform selectivity07/15/2019

Compared with coumarin, 7-hydroxycoumarin could serve as a better hit for developing CYP2A6 inhibitors. In this study, a series of 7-hydroxycoumarin and its structural analogues were collected to study their structure-activity relationship (SAR) and isoform selectivity for inhibiting CYP2A6. All...detailed

93-35-6Relevant academic research and scientific papers

Fluorescence detection of hydroxyl radical generated from oxygen reduction on Fe/N/C catalyst

Chen, Li-Na,Yu, Wen-Song,Wang, Tao,Yang, Xiao-Dong,Yang, Hui-Juan,Chen, Zhi-Xin,Wang, Tan,Tian, Na,Zhou, Zhi-You,Sun, Shi-Gang

, p. 198 - 202 (2020)

Pyrolyzed Fe/N/C catalyst has been considered as the most promising candidate to replace Pt for oxygen reduction reaction (ORR) in fuel cells. However, poor stability of Fe/N/C catalyst, mainly attributed to the oxidation corrosion by aggressive ?OH radical, severely hampers its applications. However, the exact mechanism for generation of ?OH is unclear yet. Herein, we developed a fluorescent method to effectively detect ?OH generated from ORR on Fe/N/C catalyst by using coumarin as a fluorescent probe. A great difference in potential dependence between ?OH and H2O2 generated from the ORR was observed, which suggests that ?OH is not generated from the decomposition of H2O2 as traditional viewpoint.

Hydrothermal synthesis of Mn-doped CdS hollow sphere nanocomposites as efficient visible-light driven photocatalysts

Zhang, Chunyan,Lai, Jiasheng,Hu, Juncheng

, p. 15110 - 15117 (2015)

A series of Mn-doped CdS hollow sphere photocatalysts has been directly synthesized by a simple and facile hydrothermal route for the first time. It was demonstrated that GSH acts as the S source and a gas bubble-template in this process. The products were characterized by XRD, SEM, TEM, HRTEM, XPS, and UV-vis spectroscopy. The as-prepared CdS and Mn-doped CdS hollow spheres all showed much higher activity than P25 under visible light (λ > 420 nm) irradiation. Among them, the 2.0 mol% Mn-doped CdS sample exhibited the highest photoactivity for the removal of organic pollutant RhB, and about 99.2% MO was decomposed after 50 min of visible light irradiation. Moreover, this catalyst also showed good stability, and after four cycles, the degradation efficiency still remained at 85%. The excellent photoactivity of the as-prepared Mn-doped CdS hollow spheres could be attributed to the synergistic effects of its appropriate band-gap structure and the special porous spherical morphology. The unique hollow sphere structure may favor the harvesting of excited light due to its special multiple scattering effect within the interior space, and the doping of Mn2+ may facilitate the generation of photoinduced electrons and hole pairs, and inhibit their recombination rate by acting as temporary trapping sites. This material may have great application potentials in environmental remediation and energy harvesting.

Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35)

Han, Songhee,Choi, Seunghye,Chun, Young-Jin,Yun, Chul-Ho,Lee, Chang Hoon,Shin, Hee Jung,Na, Han Sung,Chung, Myeon Woo,Kim, Donghak

, p. 394 - 399 (2012)

Cytochrome P450 2A6 (CYP2A6) catalyzes important metabolic reactions of many xenobiotic compounds, including coumarin, nicotine, cotinine, and clinical drugs. Genetic polymorphisms of CYP2A6 can influence its metabolic activities. This study analyzed the functional activities of six CYP2A6 allelic variants (CYP2A6*5,*7,*8,*18,*19, and *35) containing nonsynonymous single-nucleotide polymorphisms. Recombinant variant enzymes of CYP2A6*7,*8,*18,*19, and *35 were successfully expressed in Escherichia coli and purified. However, a P450 holoenzyme spectrum was not detected for the CYP2A6*5 allelic variant (G479V). Structural analysis shows that the G479V mutation may alter the interaction between the A helix and the F-G helices. Enzyme kinetic analyses indicated that the effects of mutations in CYP2A6 allelic variants on drug metabolism are dependent on the substrates. In the case of coumarin 7-hydroxylation, CYP2A6*8 and *35 displayed increased Km values whereas CYP2A6*18 and *19 showed decreased kcat values, which resulted in lower catalytic efficiencies (kcat/Km). In the case of nicotine 5-oxidation, the CYP2A6*19 variant exhibited an increased Km value, whereas CYP2A6*18 and *35 showed much greater decreases in kcatvalues. These results suggest that individuals carrying these allelic variants are likely to have different metabolisms for different CYP2A6 substrates. Functional characterization of these allelic variants of CYP2A6 can help determine the importance of CYP2A6 polymorphisms in the metabolism of many clinical drugs.

A sensitive and selective fluorescence probe for the detection of superoxide radical anion in vivo based on a protection-deprotection process

Chen, Liyan,Lu, Xin,Wu, Di,Xiao, Fengping

, (2021)

Superoxide radical anion (O2·?) plays vital roles in numerous physiological and pathological processes. Thus, it is in great demand to develop an efficient fluorescence probe for the measurement of O2·?. In the investigation, a new fluorescence probe NAP-SCM was developed for detection of O2·? on the basis of a protection-deprotection process. This probe, which utilizes coumarin as the fluorescent platform and 1,8-naphthalimidesulfonyl as the masking moiety, could monitor O2·? with good specificity, rapid response and low detection limit. More importantly, probe NAP-SCM displayed negligible cytotoxicity, good bio-compatibility and excellent capability of tracking the endogenous superoxide radical anion in live cells and live animals. The favorable observations illustrated that this probe has the promising potential to provide a valuable support for exploring the role(s) played by O2·? in the biologically functional processes.

Synthesis of 7-hydroxycoumarins catalysed by solid acid catalysts

Hoefnagel,Gunnewegh,Downing,Van Bekkum

, p. 225 - 226 (1995)

Syntheses of substituted 7-hydroxycoumarins via reactions of 1,3-dihydroxybenzene with ethyl acetoacetate (Pechmann reaction) and with propenoic acid and propynoic acids are reported, in which the production of environmentally harmful waste streams is minimized by the use of solid acid catalysts.

Sn-Doped defect pyrochlore oxide KNbWO6·H2O microcrystals and their photocatalytic reduction of CO2

Zeng, Xu,Chen, Yan,Jiao, Shihui,Fang, Zhenxing,Wang, Boran,Pang, Guangsheng,Feng, Shouhua

, p. 5753 - 5758 (2018)

It is highly desirable to develop new semiconductors for the photocatalytic reduction of CO2 to CH4 and CO to solve greenhouse effect and energy issues. Defect pyrochlore oxides have a flexible composition and the electron/hole mobility can be manipulated by introducing foreign cations into the structure. Through Sn doping into the defect pyrochlore oxide KNbWO6·H2O, we successfully obtained a 2-times higher photocatalytic activity for converting CO2 to CO, CH4 and O2 compared to the original KNbWO6·H2O. According to the data from UV-vis, photoluminescence, and hydroxyl radical amount-related fluorescence spectra, and CO2 adsorption, the improved photocatalytic activity can be attributed to the extended visible light response, the enhanced charge separation and the improved CO2 adsorption due to Sn doping. Our results provide a new strategy for developing high-performance photocatalysts.

Surface-Binding Peptide Facilitates Electricity-Driven NADPH-Free Cytochrome P450 Catalysis

Zernia, Sarah,Frank, Ronny,Wei?e, Renato H.-J.,Jahnke, Heinz-Georg,Bellmann-Sickert, Kathrin,Prager, Andrea,Abel, Bernd,Str?ter, Norbert,Robitzki, Andrea,Beck-Sickinger, Annette G.

, p. 525 - 530 (2018)

Industrial biotechnology aims to exploit cytochrome P450 enzymes to access their sophisticated catalytic activity for challenging chemical reactions on inert C?H bonds. Limited by the need for NADPH, approaches to bind P450 enzymes to electrode surfaces for an artificial electron supply are promising. Here, we demonstrate that a recombinant fusion of an indium tin oxide binding peptide and the multi-domain class VIII cytochrome P450 BM3 can be used in electrically driven catalysis. Bioelectrocatalytic activity is analyzed by direct product quantification resulting in superior activity of the specifically immobilized P450 BM3 in contrast to unspecifically adsorbed enzyme. Spacer and anchor point studies imply that enzyme flexibility and alignment are crucial factors to achieve high activity on the electrode. Furthermore, we demonstrate that our approach is also feasible for pharmaceutical application using naringenin as substrate.

LICRED: A versatile drop-in vector for rapid generation of redox-self-sufficient cytochrome P450s

Sabbadin, Federico,Hyde, Ralph,Robin, Aelig,Hilgarth, Eva-Maria,Delenne, Marie,Flitsch, Sabine,Turner, Nicholas,Grogan, Gideon,Bruce, Neil C.

, p. 987 - 994 (2010)

Cytochromes P450 (P450s) are a family of haem-containing oxidases with considerable potential as tools for industrial biocatalysis. Organismal genomes are revealing thousands of gene sequences that encode P450s of as yet unknown function, the exploitation of which will require high-throughput tools for their isolation and characterisation. In this report, a ligation-independent cloning vector "LICRED" is described that enables the high-throughput generation of libraries of redox-self-sufficient P450s by fusing a range of P450 haem domains to the reductase of P450RhF (RhF-Red) in a robust and generically applicable way. Cloning and expression of fusions of RhF-Red with the haem domains of P450cam and P450-XplA resulted in soluble, active, redox-self-sufficient, chimeric enzymes. In vitro studies also revealed that electron transfer from NADPH to haem was primarily intramolecular. The general applicability of the LICRED platform was then demonstrated through the creation of a library of RhF-Red fusion constructs by using the diverse complement of P450 haem domains identified in the genome of Nocardia farcinica. The resultant fusion-protein library was then screened against a panel of substrates; this revealed chimeric enzymes competent for the hydroxylation of testosterone and methyltestosterone, and the dealkylation of 7-ethoxycoumarin.

New fluorogenic probes for neutral and alkaline ceramidases

Casasampere, Mireia,Bielsa, Núria,Riba, Daniel,Bassas, Laura,Xu, Ruijuan,Mao, Cungui,Fabriàs, Gemma,Abad, José-Luis,Delgado, Antonio,Casas, Josefina

, p. 1174 - 1181 (2019)

New fluorogenic ceramidase substrates derived from the N-acyl modification of our previously reported probes (RBM14) are reported. While none of the new probes were superior to the known RBM14C12 as acid ceramidase substrates, the corresponding nervonic acid amide (RBM14C24:1) is an efficient and selective substrate for the recombinant human neutral ceramidase, both in cell lysates and in intact cells. A second generation of substrates, incorporating the natural 2-(N-acylamino)-1,3-diol-4-ene framework (compounds RBM15) is also reported. Among them, the corresponding fatty acyl amides with an unsaturated N-acyl chain can be used as substrates to determine alkaline ceramidase (ACER)1 and ACER2 activities. In particular, compound RBM15C18:1 has emerged as the best fluorogenic probe reported so far to measure ACER1 and ACER2 activities in a 96-well plate format.

Is surface fluorination of TiO2 effective for water purification? The degradation vs. mineralization of phenolic pollutants

Ryu, Jungho,Kim, Wooyul,Kim, Jaesung,Ju, Jinjung,Kim, Jungwon

, p. 24 - 30 (2017)

The photocatalytic activity of surface fluorinated TiO2 (F-TiO2) for both the degradation and mineralization of bisphenol A (BPA) was compared with that of pure TiO2. The degradation rate of BPA (i.e., the conversion rate of BPA to intermediates) was enhanced, but the mineralization rate (i.e., the conversion rate of BPA to CO2) was reduced by surface fluorination. These behaviors are different from the general trend in photocatalysis, in which the photocatalyst with a higher activity for the degradation also shows a higher activity for the mineralization. The surface fluorination of TiO2 enhanced the production of the hydroxyl radical ([rad]OH), which is primarily responsible for the degradation of BPA, by altering the [rad]OH generation pathway. However, the lower mineralization on F-TiO2, which produced more [rad]OH, implies that the role of [rad]OH in the photocatalytic mineralization process is minor. The production of superoxide/hydroperoxyl radical (O2[rad]?/HO2[rad]), which is suggested as an essential oxidant for the mineralization of phenolic pollutants, by F-TiO2 was lower than that exhibited by pure TiO2. The reduced photocurrent (Iph) generation and the enhanced H2O2 production on F-TiO2 indicate that fluorides on the TiO2 surface reduce the interfacial electron transfer rate (i.e., the production of O2[rad]?/HO2[rad]) and enhance the reduction of O2[rad]?/HO2[rad] to H2O2. The degradation rate increased, but the mineralization efficiency decreased with increasing the surface coverage of fluorides, which depends on the pH and fluoride concentration in the solution. The reduced mineralization efficiency of other phenolic pollutants (4-chlorophenol, phenol, methylene blue, rhodamine B, and acid orange 7) was also observed on F-TiO2. This result indicates that the negative effect of surface fluorination on the mineralization of phenolic pollutants is pervasive and is not restricted to BPA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 93-35-6